Insights | Schellenberg Wittmer

Perfect Holding SA announced today the completion of the reverse takeover transaction (RTO) with Kinarus AG (“Kinarus”), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of viral, respiratory, and ophthalmic disease.

Schellenberg Wittmer advised Kinarus in this transaction. The team consisted of Oliver Triebold, Marcel Jakob, Pascal Hubli, Nicolas Kurz, Laura Roth, Irisi Arifi (all Corporate/M&A), Olivier Favre, Fabio Elsener, Dominic Wälchli, Daniel Reinger (all Banking & Finance), Michael Nordin, Roland Wild (all Tax), Lorenza Ferrari Hofer, Dimitry Bölsterli (IP/Life Sciences).